Fuller & Thaler Asset Management
UTMD icon

Fuller & Thaler Asset Management’s Utah Medical Products UTMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-800
Closed -$48K – 786
2016
Q3 		$48K Hold
800
– – ﹤0.01% 600
2016
Q2 		$50K Hold
800
– – ﹤0.01% 580
2016
Q1 		$50K Buy
+800
New +$47.2K ﹤0.01% 544

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fuller & Thaler Asset Management's UTMD Position: Q4 2016 in Review

Fuller & Thaler Asset Management sold out of Utah Medical Products (UTMD) in Q4 2016, closing a stake of 800 shares — an estimated $48K sold.

Fuller & Thaler Asset Management first reported a position in UTMD in Q1 2016 and held it in 3 quarters. The position peaked at $50K in Q2 2016. 75 funds tracked by Wall St. Rank hold UTMD as of Q4 2016.

  • Fuller & Thaler Asset Management reported no remaining Utah Medical Products position as of Q4 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 800 Utah Medical Products shares in Q4 2016, an estimated $48K.
  • Fuller & Thaler Asset Management first reported a position in Utah Medical Products in Q1 2016 and held it in 3 quarters.
  • Fuller & Thaler Asset Management's Utah Medical Products position peaked at $50K in Q2 2016.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2016, filed 7 Feb 2017.